Difference between revisions of "LncRNAWiki:Featured"

From LncRNAWiki
Jump to: navigation, search
 
(62 intermediate revisions by 4 users not shown)
Line 1: Line 1:
−
<div style="padding:0.2em 0.5em;text-align:right;font-size:125%;font-weight:bold;color:#2d2d2d;">
 
−
Jump to section in alphabetical order :  [[LncRNAWiki:A|'''A''']] [[LncRNAWiki:B|'''B''']] [[LncRNAWiki:C|'''C''']] [[LncRNAWiki:D|'''D''']] [[LncRNAWiki:E|'''E''']] [[LncRNAWiki:F|'''F''']] [[LncRNAWiki:G|'''G''']] [[LncRNAWiki:H|'''H''']] [[LncRNAWiki:I|'''I''']] [[LncRNAWiki:J|'''J''']] [[LncRNAWiki:K|'''K''']] [[LncRNAWiki:L|'''L''']] [[LncRNAWiki:M|'''M''']] [[LncRNAWiki:N|'''N''']] [[LncRNAWiki:O|'''O''']] [[LncRNAWiki:P|'''P''']] [[LncRNAWiki:R|'''R''']] [[LncRNAWiki:S|'''S''']] [[LncRNAWiki:T|'''T''']] [[LncRNAWiki:U|'''U''']] [[LncRNAWiki:V|'''V''']] [[LncRNAWiki:W|'''W''']] [[LncRNAWiki:X|'''X''']] [[LncRNAWiki:Y|'''Y''']] [[LncRNAWiki:Z|'''Z''']]
 
−
</div>
 
−
 
 
{|class="wikitable sortable" style="width:90%;text-align:center"
 
{|class="wikitable sortable" style="width:90%;text-align:center"
 
|-
 
|-
−
!width="50"|Name
+
!width="50"|LncBook ID
−
!width="50"|Transcript ID
+
!width="50"|Symbol
−
!width="50"|Alias
+
!width="50"|Synonyms
−
!width="50"|Description
+
!width="50"|Functional Mechanism
 +
!width="50"|Biological Process
 
!width="50"|Disease
 
!width="50"|Disease
 +
!width="50"|Mesh Ontology
 
|-
 
|-
−
|''21A''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289501 HSALNT0289501]
−
|[[NONHSAT128494]]
+
|[[HPVC1]]
−
|ncRNA 21A
+
|PE5L,HPV18E5L
−
|N/A
+
|NA
−
|_
+
|pathogenic process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''7SK''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289605 HSALNT0289605]
−
|[[NONHSAT113149]]
+
|[[NONHSAT104559]]
−
|"7-3 RNA, K-RNA, 7SK-RNA, 7SK snRNA, RN7SK, ENSG00000202198"
+
|lnc-C9orf53-2:1
−
|"RNA, 7SK small nuclear"
+
|NA
−
|AIDS,cardiac hypertrophy,gastric cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''7SL''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0199632 HSALNT0199632]
−
|[[lnc-LRR1-1:1]]
+
|[[N4BP2L2-IT2]]
−
|"7S RNA, SRP RNA, 4.5S SRP RNA, 4.5S RNA, RN7SL1 RNA, ENSG00000258486"
+
|CG030
−
|"RNA, 7SL, cytoplasmic 1"
+
|NA
−
|AIDS,dermatomyositis
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''ABALON''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0171094 HSALNT0171094]
−
|[[ABALON]]
+
|[[LINC01150]]
−
|INXS
+
|2G7,TCONS_00019134
−
|apoptotic BCL2L1-antisense long non-coding RNA
+
|NA
−
|tumor
+
|pathogenic process
 +
|Wilms' tumor
 +
|Neoplasms
 
|-
 
|-
−
|''AIRN''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289115 HSALNT0289115]
−
|[[ENST00000609176.1]]
+
|[[LINC01587]]
−
|"AIR, IGF2RAS"
+
|C4orf6,aC1
−
|Antisense of IGF2R non-protein coding RNA
+
|NA
−
|alcoholic liver disease,chronic nonalcoholic liver disease, hepatocelluar carcinoma
+
|pathogenic process
 +
|neuroblastoma
 +
|Neoplasms
 
|-
 
|-
−
|''APOA1-AS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290105 HSALNT0290105]
−
|[[ENST00000444200.1]]
+
|[[NONHSAT115106]]
−
|APOA1 antisense RNA
+
|NONHSAT115106
−
|N/A
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''APTR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289234 HSALNT0289234]
−
|[[NONHSAT121673]]
+
|[[RNF217-AS1]]
−
|Alu-mediated CDKN1A/p21
+
|STL
−
|N/A
+
|NA
−
|liver cirrhosis
+
|pathogenic process
 +
|acute lymphoblastic leukemia
 +
|Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases
 
|-
 
|-
−
|''BANCR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0280481 HSALNT0280481]
−
|[[BANCR]]
+
|[[INE2]]
−
|LINC00586
+
|NCRNA00011
−
|BRAF-activated non-protein coding RNA
+
|NA
−
|osteosarcoma, hepatocellular carcinoma, gastric cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''BDNF-AS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289485 HSALNT0289485]
−
|[[ENST00000499008.3]]
+
|[[INE1]]
−
|BDNF antisense RNA
+
|NCRNA00010
−
|"BT2A, BT2B,BT2C,BT2D,NCRNA00049,BDNF-AS1, NCRNA00049"
+
|NA
−
|Huntington's disease, psychiatric disease, schizophrenia, obesity
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''BLACAT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289511 HSALNT0289511]
−
|[[BLACAT1]]
+
|[[LINC01565]]
−
|"linc-UBC1,LINC00912, onco-lncRNA-30"
+
|C3orf27,GR6
−
|bladder cancer associated transcript 1 (non-protein coding)
+
|NA
−
|bladder cancer
+
|pathogenic process
 +
|leukemia
 +
|Neoplasms
 
|-
 
|-
−
|''CAHM''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289068 HSALNT0289068]
−
|[[ENST00000604200.1]]
+
|[[LINC00869]]
−
|LINC00468
+
|KIAA0493
−
|colon adenocarcinoma hypermethylated (non-protein coding)
+
|NA
−
|colorectal neoplasia.
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''PTCSC1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289430 HSALNT0289430]
−
|[[NONHSAT129210]]
+
|[[ERC2-IT1]]
−
|AK023948
+
|C1orf1,C3orf51,Po42
−
|papillary thyroid carcinoma susceptibility candidate 1 (non-protein coding)
+
|NA
−
|thyroid carcinoma
+
|pathogenic process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''BCYRN1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290394 HSALNT0290394]
−
|[[lnc-EPCAM-1:2]]
+
|[[Lnc-PDIA4-1:1]]
−
|"BC200,BC200a, NCRNA00004, LINC00004"
+
|lnc-PDIA4-1:1
−
|"BCYRN1, brain cytoplasmic RNA 1"
+
|NA
−
|Alzheimer's disease,breast cancer,cervical cancer, lung cancer,oesophagus cancer, ovarian cancer, parotid cancer,tongue cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''BPESC1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289195 HSALNT0289195]
−
|[[ENST00000418282.1]]
+
|[[NOP14-AS1]]
−
|NCRNA00187
+
|C4orf10,RES4-24
−
|"blepharophimosis, epicanthus inversus and ptosis, candidate 1 (non-protein coding)"
+
|NA
−
|blepharophimosis syndrome
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''CYP4A22-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290309 HSALNT0290309]
−
|[[ENST00000444042.2]]
+
|[[NONHSAT022116]]
−
|"Noncoding RNA activating3: ncRNA-a3, ENST00000444042.2, ENSG00000225506"
+
|NONHSAT022116,AF080092,TSU
−
|CYP4A22 antisense RNA 1
+
|NA
−
|_
+
|developmental process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''CASC8''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289243 HSALNT0289243]
−
|[[CASC8]]
+
|[[SMAD5-AS1]]
−
|"LINC00860,CARLo-1"
+
|SMAD5O,DAMS
−
|cancer susceptibility candidate 8 (non-protein coding)
+
|NA
−
|Colorectal Cancer,Lung Cancer
+
|pathogenic process
 +
|malignant hematopoietic
 +
|Cell Physiological Phenomena
 
|-
 
|-
−
|''CCAT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289025 HSALNT0289025]
−
|[[NONHSAT129017]]
+
|[[LINC00244]]
−
|"CARLo-5, onco-lncRNA-40"
+
|C7orf4,NCRNA00244
−
|colon cancer associated transcript 1 (non-protein coding)
+
|NA
−
|colorectal cancer,gastric cancer
+
|pathogenic process
 +
|preaxial polydactyly
 +
|NA
 
|-
 
|-
−
|''CCAT2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289017 HSALNT0289017]
−
|[[CCAT2]]
+
|[[KIF25-AS1]]
−
|"NCCP1, LINC00873"
+
|C6orf54,NCRNA00300,HGC6.1.1
−
|colon cancer associated transcript 2 (non-protein coding)
+
|NA
−
|non-small cell lung cancer
+
|pathogenic process
 +
|ovarian cancer
 +
|Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 
|-
 
|-
−
|''CISTR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289332 HSALNT0289332]
−
|[[NONHSAT028496]]
+
|[[LINC01558]]
−
|"CISTR-ACT, CISTRACT, re52431"
+
|C6orf123,LINC01557,HGC6.2,dJ431P23.4
−
|chondrogenesis-associated transcript
+
|NA
−
|_
+
|pathogenic process
 +
|ovarian cancer
 +
|Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 
|-
 
|-
−
|''CRNDE''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289438 HSALNT0289438]
−
|[[Lnc-IRX3-4:2]]
+
|[[AFDN-AS1]]
−
|"LOC643911, LINC00180, CRNDEP"
+
|C6orf124,MLLT4-AS1,HGC6.4,dJ431P23.3
−
|colorectal neoplasia differentially expressed (non-protein coding)
+
|NA
−
|colorectal cancer
+
|pathogenic process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''CYYR1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289232 HSALNT0289232]
−
|[[ENST00000357401.3]]
+
|[[RFPL3S]]
−
|cysteine and tyrosine rich 1 antisense RNA 1
+
|RFPL3-AS1,RFPL3-A, NCRNA00005
−
|N/A
+
|NA
−
|_
+
|pathogenic process
 +
|opitz syndrome
 +
|NA
 
|-
 
|-
−
|''DALIR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289393 HSALNT0289393]
−
|[[DALIR]]
+
|[[RFPL1S]]
−
|DALI
+
|RFPL1-AS1,RFPL1-A, NCRNA00006
−
|DNMT1-associated long intergenic non-coding RNA
+
|NA
−
|_
+
|pathogenic process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''DANCR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289500 HSALNT0289500]
−
|[[NONHSAT096369]]
+
|[[HCG4B]]
−
|differentiation antagonizing non-protein coding RNA
+
|HCG4P6,HCGIV-6,HCGIV.5,HCGIV-06,bCX67J3.3,Em:AB023056.16,bPG309N1.1,bQB90C11.3
−
|"ANCR, AGU2, lncRNA-ANCR"
+
|NA
−
|bone diseases
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''DBET''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289894 HSALNT0289894]
−
|[[NONHSAT099821]]
+
|[[LINC00294]]
−
|"DBE-T, DUX4L30"
+
|NA
−
|D4Z4 binding element transcript (non-protein coding)
+
|NA
−
|Pancreatic ductal adenocarcinoma, Facioscapulohumeral muscular dystrophy
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''DHFR upstream transcripts''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289345 HSALNT0289345]
−
|[[NONHSAT102417]]
+
|[[LINC00893]]
−
|"DHFR minor transcript 5'-UTR, ENSG00000228716"
+
|NA
−
|N/A
+
|NA
−
|_
+
|pathogenic process
 +
|hunter syndrome
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities
 
|-
 
|-
−
|''DHRS4-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290133 HSALNT0290133]
−
|[[NONHSAT035954]]
+
|[[PCBP3-OT1]]
−
|DHRS4 antisense RNA 1
+
|PCBP3-OT1,FLJ44028
−
|"PRO1488,AS1DHRS4"
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''DLEU1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289488 HSALNT0289488]
−
|[[NONHSAT033797]]
+
|[[ENST00000418282.1]]
−
|deleted in lymphocytic leukemia 1 (non-protein coding)
+
|NCRNA00187
−
|"LEU1, XTP6, NCRNA00021, LINC00021, BCMS1"
+
|NA
−
|chronic lymphocytic leukemia
+
|pathogenic process
 +
|blepharophimosis syndrome
 +
|Eye Diseases
 
|-
 
|-
−
|''DLEU2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289712 HSALNT0289712]
−
|[[NONHSAT033821]]
+
|[[COPG2IT1]]
−
|deleted in lymphocytic leukemia 2 (non-protein coding)
+
|CIT1,NCRNA00170,COPG2AS
−
|"LEU2, TRIM13OS, NCRNA00022, LINC00022, MIR15AHG"
+
|NA
−
|chronic lymphocytic leukemia, lymphocytic leukemia, myeloma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''DISC2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0265040 HSALNT0265040]
−
|[[NONHSAT010191]]
+
|[[LINC00652]]
−
|"DISC1-AS1, DISC1OS, NCRNA00015"
+
|HSPC072
−
|disrupted in schizophrenia 2 (non-protein coding)
+
|NA
−
|affective disorders, Autism spectrum disorder, bipolar disorder, depression, schizophrenia
+
|developmental process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''EGOT''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289282 HSALNT0289282]
−
|[[NONHSAT087635]]
+
|[[WASIR2]]
−
|"EGO, ""eosinophil granule ontogeny"", NCRNA00190, ""non-protein coding RNA 190"", ENSG00000235947"
+
|NCRNA00286A
−
|Eosinophil granule ontogeny (EGO) RNA
+
|NA
−
|breast cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''EMX2OS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0246856 HSALNT0246856]
−
|[[lnc-PDZD8-3:1]]
+
|[[LINC00470]]
−
|"EMX2-AS1, NCRNA00045, ""non-protein coding RNA 45"",ENSG00000229847"
+
|C18orf2
−
|Emx2 opposite strand transcript.
+
|NA
−
|_
+
|pathogenic process
 +
|age-related macular degeneration
 +
|Eye Diseases
 
|-
 
|-
−
|''ERICD''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289507 HSALNT0289507]
−
|[[Lnc-CHRAC1-2:1]]
+
|[[LINC00588]]
−
|"TCONS_00014875, ERIC"
+
|C8orf71,DKFZP434F122
−
|E2F1-regulated inhibitor of cell death (non-protein coding)
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''ESRG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0276604 HSALNT0276604]
−
|[[ENST00000583516.1]]
+
|[[TTC28-AS1]]
−
|HESRG
+
|TTC28AS,TTC28-AS,KIAA1648
−
|embryonic stem cell related (non-protein coding)
+
|NA
−
|embryonal carcinoma, intracranial aneurism
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''Evf2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0237577 HSALNT0237577]
−
|[[lnc-DLX5-3:1]]
+
|[[CDRT7]]
−
|"Evf-2, Dlx6as1, Dlx6os1, ENSG00000231764"
+
|NCRNA00025,LINC00025
−
|_
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''FENDRR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288912 HSALNT0288912]
−
|[[FENDRR]]
+
|[[CDRT8]]
−
|FOXF1 adjacent non-coding developmental regulatory RNA
+
|NA
−
|"lincFOXF1, onco-lncRNA-21"
+
|NA
−
|Heart Failure
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''FIRRE''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0275048 HSALNT0275048]
−
|[[ENST00000427391.1]]
+
|[[CECR3]]
−
|firre intergenic repeating RNA element
+
|NA
−
|LINC01200
+
|NA
−
|_
+
|pathogenic process
 +
|cat eye syndrome
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities
 
|-
 
|-
−
|''FOXCUT''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288915 HSALNT0288915]
−
|[[Lnc-FOXC1-1:1]],
+
|[[CECR9]]
−
[[NONHSAT106529]]
+
|NA
−
|TCONS_00011636
+
|NA
−
|FOXC1 upstream transcript (non-protein coding)
+
|pathogenic process
−
|esophageal squamous cell carcinoma, basal-like breast cancer
+
|cat eye syndrome
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities
 
|-
 
|-
−
|''FTX''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288998 HSALNT0288998]
−
|[[ENST00000602812.1]]
+
|[[HDHD5-AS1]]
−
|"LINC00182,FLJ33139"
+
|CECR4,CECR5-AS1,NCRNA00017
−
|"FTX transcript, XIST regulator (non-protein coding)"
+
|NA
−
|epatocellular carcinoma, colorectal cancer
+
|pathogenic process
 +
|cat eye syndrome
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities
 
|-
 
|-
−
|''GHET1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288914 HSALNT0288914]
−
|[[GHET1]]
+
|[[CECR5-AS1]]
−
|lncRNA-GHET1
+
|NCRNA00017
−
|gastric carcinoma proliferation enhancing transcript 1
+
|NA
−
|gastric cancer
+
|pathogenic process
 +
|cat eye syndrome
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities
 
|-
 
|-
−
|''GHRLOS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288919 HSALNT0288919]
−
|[[NONHSAT087920]]
+
|[[CLRN1-AS1]]
−
|"NCRNA00068,GHRL-AS1"
+
|CLRN1O,UCRP
−
|ghrelin opposite strand/antisense RNA
+
|NA
−
|obesity, diabetes and cancer
+
|pathogenic process
 +
|usher syndrome type 3
 +
|NA
 
|-
 
|-
−
|''GPR1-AS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289271 HSALNT0289271]
−
|[[NONHSAT076558]]
+
|[[TMEM9B-AS1]]
−
|GPR1AS
+
|C11orf18
−
|GPR1 antisense RNA
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''HAGLR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289324 HSALNT0289324]
−
|[[ENST00000416928.2]],
+
|[[LINC01547]]
−
[[NONHSAT075638]]
+
|C21orf69,C21orf67
−
|Mdgt
+
|NA
−
|HOXD antisense growth-associated long non-coding RNA
+
|pathogenic process
−
|neuroblastoma
+
|Down syndrome
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
 
|-
 
|-
−
|''HEIH''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0270409 HSALNT0270409]
−
|[[HEIH]]
+
|[[LINC00029]]
−
|"LINC-HEIH, lncRNA-HEIH, LINC00848, HCCAT2"
+
|C20orf51,NCRNA00029,bA305P22.4
−
|hepatocellular carcinoma up-regulated EZH2-associated long non-coding RNA
+
|NA
−
|hepatocelluar carcinoma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''JADRR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289336 HSALNT0289336]
−
|[[JADRR]]
+
|[[LINC00529]]
−
|lncRNA-JADE
+
|C8orf8
−
|JADE1 adjacent regulatory RNA
+
|NA
−
|breast cancer
+
|pathogenic process
 +
|keratolytic winter erythema
 +
|NA
 
|-
 
|-
−
|''KANTR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288978 HSALNT0288978]
−
|[[ENST00000604849.1]]
+
|[[FLVCR1-AS1]]
−
|KDM5C adjacent non-coding transcript
+
|FLVCR1-DT,LQK1
−
|Spasm
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LINC-PINT''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0238050 HSALNT0238050]
−
|[[NONHSAT123382]]
+
|[[SMCR2]]
−
|"FLJ43663, PINT, LincRNA-Pint"
+
|NA
−
|"long intergenic non-protein coding RNA, p53 induced transcript"
+
|NA
−
|pancreatic cancer
+
|pathogenic process
 +
|Smith-Magenis syndrome
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
 
|-
 
|-
−
|''LINC00163''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289401 HSALNT0289401]
−
|[[LINC00163]]
+
|[[SMCR5]]
−
|"NLC1-A, NLC1A"
+
|NCRNA00034
−
|long intergenic non-protein coding RNA 163
+
|NA
−
|_
+
|pathogenic process
 +
|Smith-Magenis syndrome
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
 
|-
 
|-
−
|''LINC00312''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290246 HSALNT0290246]
−
|[[NONHSAT087716]]
+
|[[SMCR6]]
−
|"NAG7, NAG-7, ERR10, LMCD1DN, ERR-10"
+
|NA
−
|long intergenic non-protein coding RNA 312
+
|NA
−
|nasopharyngeal carcinoma
+
|pathogenic process
 +
|Smith-Magenis syndrome
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
 
|-
 
|-
−
|''LINC00850''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0274626 HSALNT0274626]
−
|[[LINC00850]]
+
|[[LINC00205]]
−
|KUCG1
+
|C21orf86,NCRNA00205,
−
|long intergenic non-protein coding RNA 850
+
|NA
−
|_
+
|pathogenic process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LINC01191''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0271512 HSALNT0271512]
−
|[[ENST00000412690.1]]
+
|[[C21orf91-OT1]]
−
|"VIN, lnc-ACTR3"
+
|NCRNA00285,D21S2089E
−
|long intergenic non-protein coding RNA 1191
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LSINCT5''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0272596 HSALNT0272596]
−
|[[LSINCT5]]
+
|[[LINC00307]]
−
|N/A
+
|NCRNA00307,D21S2091E
−
|long stress-induced non-coding transcript 5
+
|NA
−
|gastric cancer,breast and ovarian cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LUCAT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0274502 HSALNT0274502]
−
|[[ENST00000511918.1]]
+
|[[TSPEAR-AS2]]
−
|SCAL1
+
|C21orf90
−
|lung cancer associated transcript 1 (non-protein coding)
+
|NA
−
|non-small cell lung cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''MIR22HG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0274807 HSALNT0274807]
−
|[[ENST00000574306.1]]
+
|[[MCM3AP-AS1]]
−
|"MGC14376, DKFZp686O06159, LOC554202"
+
|C21orf85,MCM3APAS,MCM3AP-AS,FLJ10508,NCRNA00031
−
|MIR22 host gene
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''MIR31HG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288888 HSALNT0288888]
−
|[[NONHSAT130385]]
+
|[[B3GALT5-AS1]]
−
|LOC554202
+
|C21orf88
−
|MIR31 host gene
+
|NA
−
|gastric cancer, pancreatic ductal adenocarcinoma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''MIR99AHG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288898 HSALNT0288898]
−
|[[ENST00000602580.1]]
+
|[[BRWD1-AS2]]
−
|MONC
+
|C21orf87,NCRNA00257,BRWD1-IT2
−
|mir-99a-let-7c cluster host gene
+
|NA
−
|myeloid leukemia
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''MIR100HG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289031 HSALNT0289031]
−
|[[ENST00000531381.1]]
+
|[[LINC00315]]
−
|"AGD1, lncRNA-N2"
+
|C21orf93,NCRNA00315
−
|mir-100-let-7a-2 cluster host gene
+
|NA
−
|myeloid leukemia
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''MIR155HG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289033 HSALNT0289033]
−
|[[NONHSAT081499]]
+
|[[LINC00334]]
−
|"BIC, NCRNA00172"
+
|C21orf89,NCRNA00334
−
|MIR155 host gene
+
|NA
−
|chronic lymphocytic leukemia
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''MIR222HG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289322 HSALNT0289322]
−
|[[ENST00000602507.1]]
+
|[[LINC00314]]
−
|Lnc-Ang362
+
|C21orf94,NCRNA00314
−
|MIR222 host gene
+
|NA
−
|Ang II-associated cardiovascular disease
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''MIR503HG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0271821 HSALNT0271821]
−
|[[ENST00000414769.1]]
+
|[[LINC00308]]
−
|"MGC16121, H19X"
+
|C21orf74,NCRNA00308,PRED16
−
|MIR503 host gene
+
|NA
−
|choriocarcinoma
+
|pathogenic process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''MYCNUT''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289023 HSALNT0289023]
−
|[[ENST00000433810.1]]
+
|[[LINC00189]]
−
|lncUSMycN
+
|C21orf109,NCRNA00189
−
|MYCN upstream transcript (non-protein coding)
+
|NA
−
|neuroblastoma
+
|pathogenic process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''NAMA''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289375 HSALNT0289375]
−
|[[ENST00000604258.1]]
+
|[[NCRUPAR]]
−
|N/A
+
|ncR-uPAR,ncRuPAR,NCRNA00193
−
|"non-protein coding RNA, associated with MAP kinase pathway and growth arrest"
+
|transcriptional regulation
−
|papillary thyroid carcinoma
+
|developmental process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''NRIR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0273467 HSALNT0273467]
−
|[[ENST00000414795.1]]
+
|[[DSCR10]]
−
|lncRNA-CMPK2
+
|NA
−
|negative regulator of interferon response (non-protein coding)
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''OIP5-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289480 HSALNT0289480]
−
|[[ENST00000500949.2]]
+
|[[DSCR9]]
−
|"cyrano,LOC729082, linc-NUSAP1-1, OIP5-AS1"
+
|NCRNA00038
−
|OIP5 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''OVAAL''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290051 HSALNT0290051]
−
|[[ENST00000442621.1]]
+
|[[MDS2]]
−
|"LINC01131,OVAL"
+
|NA
−
|ovarian adenocarcinoma amplified long non-coding RNA
+
|NA
−
|ovarian cancer
+
|pathogenic process
 +
|myelodysplastic syndrome
 +
|Hemic and Lymphatic Diseases
 
|-
 
|-
−
|''PACERR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0127810 HSALNT0127810]
−
|[[ENST00000608917.1]]
+
|[[ST7-AS2]]
−
|"PACER, PTGS2-AS1"
+
|ST7OT2,ST7AS2
−
|PTGS2 antisense NFKB1 complex-mediated expression regulator RNA
+
|NA
−
|inflammation and cancer
+
|pathogenic process
 +
|autism
 +
|Mental Disorders
 
|-
 
|-
−
|''PART1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0127813 HSALNT0127813]
−
|[[ENST00000506884.1]]
+
|[[ST7-OT3]]
−
|"DKFZP586D0823, NCRNA00206"
+
|ST7OT3,NCRNA00026
−
|prostate androgen-regulated transcript 1 (non-protein coding)
+
|NA
−
|prostate carcinogenesis
+
|pathogenic process
 +
|autism
 +
|Mental Disorders
 
|-
 
|-
−
|''PAUPAR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290258 HSALNT0290258]
−
|[[NONHSAT018635]]
+
|[[ST7-OT4]]
−
|N/A
+
|NA
−
|PAX6 upstream antisense RNA
+
|NA
−
|_
+
|pathogenic process
 +
|autism
 +
|Mental Disorders
 
|-
 
|-
−
|''PCA3''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290257 HSALNT0290257]
−
|[[ENST00000412654.1]]
+
|[[NONHSAT122926]]
−
|"DD3, NCRNA00019, PCAT3"
+
|NONHSAT122926
−
|prostate cancer associated 3 (non-protein coding)
+
|NA
−
|Prostate Cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''PCAT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289372 HSALNT0289372]
−
|[[ENST00000561978.1]]
+
|[[MIR600HG]]
−
|"PCAT-1, PCA1"
+
|C9orf45,NCRNA00287,GL012,FLJ22161
−
|prostate cancer associated transcript 1 (non-protein coding)
+
|NA
−
|Prostate Cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''PCAT4''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0013239 HSALNT0013239]
−
|[[ENST00000504263.1]]
+
|[[ATP1A1-AS1]]
−
|"GDEP, PCAN1, PCA4"
+
|C1orf203,ATP1A1OS,MGC16179
−
|prostate cancer associated transcript 4 (non-protein coding)
+
|NA
−
|Prostate Cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''PCAT7''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0048563 HSALNT0048563]
−
|[[ENST00000452148.2]]
+
|[[SPATA3-AS1]]
−
|PCAN-R2
+
|NA
−
|prostate cancer associated transcript 7 (non-protein coding)
+
|NA
−
|Prostate Cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''PRNCR1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0050859 HSALNT0050859]
−
|[[NONHSAT129019]]
+
|[[LINC00852]]
−
|N/A
+
|C3orf42,GHRLOS2,NAG73,GHRL-AS2
−
|prostate cancer associated non-coding RNA 1
+
|NA
−
|Prostate Cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''PTCSC2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0069395 HSALNT0069395]
−
|[[ENST00000430058.1]]
+
|[[LINC01096]]
−
|N/A
+
|NA
−
|papillary thyroid carcinoma susceptibility candidate 2 (non-protein coding)
+
|NA
−
|papillary thyroid carcinoma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''PTCSC3''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0072367 HSALNT0072367]
−
|[[ENST00000556013.2]]
+
|[[LINC02260]]
−
|N/A
+
|NA
−
|papillary thyroid carcinoma susceptibility candidate 3 (non-protein coding)
+
|NA
−
|psoriasis
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''PVT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0077259 HSALNT0077259]
−
|[[ENST00000513868.2]]
+
|[[LINC01091]]
−
|"NCRNA00079, LINC00079, onco-lncRNA-100"
+
|NA
−
|Pvt1 oncogene (non-protein coding)
+
|NA
−
|breast cancer, Burkitt's lymphomas, diabetic nephropathy, Hodgkin's lymphoma, lymphoma, murine plasmacytomas, ovarian cancer, pancreas cancer, prostate cancer,renal cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''PWRN1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0096480 HSALNT0096480]
−
|[[NONHSAT040920]]
+
|[[SAP30L-AS1]]
−
|NCRNA00198
+
|FLJ38109,GALNT10-AS1
−
|Prader-Willi region non-protein coding RNA 1
+
|NA
−
|Prader-Willi syndrome
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''PWRN2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0098558 HSALNT0098558]
−
|[[NONHSAT040875]]
+
|[[PRR7-AS1]]
−
|NCRNA00199
+
|NA
−
|Prader-Willi region non-protein coding RNA 2
+
|NA
−
|Prader-Willi syndrome
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''RASSF1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0099356 HSALNT0099356]
−
|[[RASSF1-AS1]]
+
|[[LINC01622]]
−
|RASSF1 antisense RNA 1
+
|TCONS_00011202
−
|ANRASSF1
+
|NA
−
|breast cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''SCAANT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0113415 HSALNT0113415]
−
|[[SCAANT1]]
+
|[[LINC01312]]
−
|SCA7/ATXN7 antisense RNA 1
+
|MGC34034
−
|ATXN7-AS1
+
|NA
−
|Spinocerebellar ataxia type 7
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''SCHLAP1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0134652 HSALNT0134652]
−
|[[NONHSAT075852]]
+
|[[EXTL3-AS1]]
−
|SWI/SNF complex antagonist associated with prostate cancer 1 (non-protein coding)
+
|C8orf50
−
|"SChLAP1,PCAT11"
+
|NA
−
|prostate cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''SENCR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0138253 HSALNT0138253]
−
|[[ENST00000526269.2]]
+
|[[C8orf34-AS1]]
−
|smooth muscle and endothelial cell enriched migration/differentiation-associated long non-coding RNA
+
|NA
−
|N/A
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''TARID''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0154876 HSALNT0154876]
−
|[[ENST00000607033.1]]
+
|[[PSMD5-AS1]]
−
|N/A
+
|NA
−
|TCF21 antisense RNA inducing promoter demethylation
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''WFDC21P''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0163228 HSALNT0163228]
−
|[[Lnc-HEATR6-1:4]]
+
|[[LINC01553]]
−
|"WAP four-disulfide core domain 21, pseudogene"
+
|C10orf40,AC023904.2
−
|"LOC645638, lnc-DC, LNCDC"
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''GAS5''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0175689 HSALNT0175689]
−
|[[NONHSAT007663]]
+
|[[LINC00301]]
−
|"SNHG2, ENSG00000234741"
+
|C11orf64,NCRNA00301,MGC39681
−
|_
+
|NA
−
|autoimmune disease, B-cell neoplasms, breast cancer, kidney cancer, lymphoma, prostate cancer, melanoma, systemic lupus erythaematosus
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''MIAT''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0247235 HSALNT0247235]
−
|[[lnc-CRYBA4-2:1]]
+
|[[DLGAP1-AS3]]
−
|"FLJ25967, gomafu, LINC00066, lncRNA-MIAT, ""long intergenic non-protein coding RNA 66"", NCRNA00066, ""non-protein coding RNA 66"", Rncr2"
+
|NA
−
|myocardial infarction associated transcript (non-protein coding)
+
|NA
−
|myocardial infarction
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''H19''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0254200 HSALNT0254200]
−
|[[NONHSAT017465]]
+
|[[CIRBP-AS1]]
−
|"Q96MK8,ENSG00000130600"
+
|C19orf23,MGC39338
−
|"H19, imprinted maternally expressed transcript (non-protein coding)"
+
|NA
−
|bladder cancer, breast cancer, cervical cancer, choricarcinoma, colon cancer, Congenital hyperinsulinism, Esophageal squamous cell cancer, gastric cancer, germ cell tumor, gestational choriocarcinoma, glioblastoma, glioma, growth restriction, hematopoiesis, infertility, kidney cancer, liver cancer, lung cancer, Marek's disease, Medulloblastoma, melanoma, Meningioma, Mullerian aplasia, myeloproliferative polycythaemia vera, neural tube defects, neuroblastoma, obesity, ovarian cancer, pheochromocytoma, pituitary adenoma, Prader-Willi syndrome, pre-eclampsia, prostate cancer, Silver-Russell syndrome, Wiedemann-Beckwith syndrome, Wilms' tumor
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''HAR1A''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0257335 HSALNT0257335]
−
|[[lnc-BIRC7-2:1]]
+
|[[LINC01785]]
−
|"HAR1F, ENSG00000238820"
+
|NA
−
|highly accelerated region 1A
+
|NA
−
|Alzheimer's disease,Huntington's disease, schizophrenia
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''HAR1B''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0261582 HSALNT0261582]
−
|[[ENST00000447910.2]]
+
|[[LINC01869]]
−
|"HAR1R, ENSG00000231133"
+
|MGC45922
−
|highly accelerated region 1B
+
|NA
−
|Huntington's disease, schizophrenia
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''HOTAIR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0269743 HSALNT0269743]
−
|[[NONHSAT028508]]
+
|[[LINC01711]]
−
|"Gm16258, Hox antisense intergenic RNA, ENSG00000228630"
+
|MGC4294
−
|Hox antisense intergenic RNA
+
|NA
−
|B-cell neoplasms,breast cancer,cervical cancer,colon cancer,colorectal cancer,endometrial cancer,gastric cancer,hepatocelluar carcinoma,laryngeal squamous cell carcinoma,liver cancer,lung adenocarcinoma,nasopharyngeal carcinoma,non-small cell lung cancer,oesophageal squamous cell carcinoma,oral squamous cell carcinoma,pancreas cancer,rheumatoid arthritis,small cell lung cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''HOTAIRM1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288468 HSALNT0288468]
−
|[[lnc-EVX1-12:1]]
+
|[[FAM41AY1]]
−
|"HIT06113, HIT92376, linc1548, ENSG00000233429"
+
|FAM41AY
−
|"HOXA transcript antisense RNA, myeloid-specific 1"
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''HOTTIP''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288899 HSALNT0288899]
−
|[[NONHSAT119717]]
+
|[[C5orf66-AS2]]
−
|"HOXA13as, HIT18844, NCRNA00213, ENSG00000243766"
+
|NA
−
|HOXA transcript at the distal tip
+
|NA
−
|hepatocelluar carcinoma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''HOXA11-AS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288922 HSALNT0288922]
−
|[[NONHSAT119704]]
+
|[[CSTF3-AS1]]
−
|"HOXA cluster antisense RNA 5 (non-protein coding), HOXA-AS5, ""HOXA11 antisense RNA 1 (non-protein coding)"", HOXA11-AS1, HOXA11S, NCRNA00076, ""non-protein coding RNA 76"", ENSG00000240990"
+
|CSTF3-DT
−
|HOXA11 antisense RNA
+
|NA
−
|glioma, ovarian cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''HOXA-AS2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288923 HSALNT0288923]
−
|[[NONHSAT119676]]
+
|[[CYP1B1-AS1]]
−
|"HOXA3as, ENSG00000253552"
+
|C2orf58,MGC34824
−
|HOXA cluster antisense RNA 2
+
|NA
−
|gastric cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''HOXA-AS3''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288957 HSALNT0288957]
−
|[[lnc-EVX1-9:1]]
+
|[[ENTPD3-AS1]]
−
|HOXA6as
+
|FLJ36665
−
|HOXA cluster antisense RNA 3
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''HULC''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288970 HSALNT0288970]
−
|[[NONHSAT107640]]
+
|[[FAM27E3]]
−
|ENSG00000251164
+
|MGC42630
−
|hepatocellular carcinoma up-regulated long non-coding RNA
+
|NA
−
|hepatocelluar carcinoma, liver cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''IPW''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288972 HSALNT0288972]
−
|[[NONHSAT041063]]
+
|[[FAM41C]]
−
|NCRNA00002
+
|NA
−
|imprinted in Prader-Willi syndrome
+
|NA
−
|Prader-Willi syndrome
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''JPX''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288977 HSALNT0288977]
−
|[[lnc-ZCCHC13-1:1]]
+
|[[FLG-AS1]]
−
|"DCBALD06, ENOX, ""expressed neighbor of XIST"", ""just proximal to XIST"", LINC00183"
+
|NA
−
|"JPX transcript, XIST activator (non-protein coding)"
+
|NA
−
|X chromosome inactivatio
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''KCNQ1OT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288983 HSALNT0288983]
−
|[[NONHSAT017524]]
+
|[[GABPB1-IT1]]
−
|"KCNQ1 antisense RNA 2 (non-protein coding), ""KCNQ1 overlapping transcript 1 (non-protein coding)"", KCNQ1-AS2, KvDMR1, KvLQT1-AS, LIT1, NCRNA00012, ""non-protein coding RNA 12"""
+
|FLJ10038
−
|KCNQ1 opposite strand/antisense transcript 1 (non-protein coding)
+
|NA
−
|Beckwith-Wiedemann syndrome,colorectal cancer,hepatocelluar carcinoma,kidney cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''KRASP1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289010 HSALNT0289010]
−
|[[NONHSAT113225]]
+
|[[ILF3-AS1]]
−
|ENSG00000220635
+
|ILF3-DT
−
|KRAS Pseudogene 1
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''FALEC''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289034 HSALNT0289034]
−
|[[ENST00000416894.1]]
+
|[[LINC00347]]
−
|"LINC00568, ""long intergenic non-protein coding RNA 568"", ENSG00000228126.1"
+
|NA
−
|focally amplified long non-coding RNA in epithelial cancer
+
|NA
−
|ovarian cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''lincRNA-ROR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289039 HSALNT0289039]
−
|[[NONHSAT059436]]
+
|[[LINC00466]]
−
|"ROR, lincRNA-ST8SIA3, ENSG00000258609"
+
|NA
−
|"long intergenic non-protein coding RNA, regulator of reprogramming"
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LOC100887755''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289040 HSALNT0289040]
−
|[[lnc-SNAI1-1:1]]
+
|[[LINC00471]]
−
|"Noncoding RNA activating7: ncRNA-a7, ENST00000431460.1,ENSG00000231265,TRERNA1"
+
|C2orf52,MGC43122
−
|translation regulatory long non-coding RNA 1
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''TUSC7''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289044 HSALNT0289044]
−
|[[NONHSAT091315]]
+
|[[LINC00526]]
−
|"LINC00902, LOC285194, ENSG00000243197"
+
|C18orf18,MGC17515,HsT959
−
|tumor suppressor candidate 7 (non-protein coding)
+
|NA
−
|colorectal cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''RBM5-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289048 HSALNT0289048]
−
|[[NONHSAT089783]]
+
|[[LINC00593]]
−
|"LUCA-15-specific transcript, LUST, ENSG00000003756"
+
|C15orf50,MGC42951
−
|RBM5 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''MALAT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289050 HSALNT0289050]
−
|[[ENST00000534336.1]]
+
|[[LINC00608]]
−
|"HCN, ""hepcarcin"", LINC00047, ""long intergenic non-protein coding RNA 47"", MALAT-1, mascRNA, ""metastasis associated in lung adenocarcinoma transcript 1"", NCRNA00047, NEAT2, ""non-protein coding RNA 47"", ""nuclear enriched abundant transcript 2"", ""nuclear paraspeckle assembly transcript 2 (non-protein coding)"", PRO1073, ENSG00000251562"
+
|NA
−
|metastasis associated lung adenocarcinoma transcript 1 (non-protein coding)
+
|NA
−
|B-cell neoplasms,bladder cancer,breast cancer, cervial cancer, colon cancer, decreased myogenesis,Diabetes, endometrial cancer, gallbladder cancer, hepatocelluar carcinoma, kidney cancer, laryngeal squamous cell carcinoma, liver cancer, lung cancer, nasopharyngeal carcinoma, neuroblastoma, non-small cell lung cancer, osteosarcoma, pancreas cancer, prostate cancer, small cell lung cancer, uterus cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''mascRNA''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289054 HSALNT0289054]
−
|[[lnc-SCYL1-1:5]]
+
|[[LINC00638]]
−
|Malat1
+
|MGC23270
−
|mascRNA (MALAT1-associated small cytoplasmic RNA)
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''MEG3''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289056 HSALNT0289056]
−
|[[NONHSAT039745]]
+
|[[LINC00661]]
−
|"Gtl2, ENSG00000214548"
+
|NA
−
|maternally expressed 3 (non-protein coding)
+
|NA
−
|bladder cancer, breast cancer, chronic myeloid leukemia, colon cancer, gastric cancer, glioma, hepatocelluar carcinoma, heroin abuse, Huntington's disease, kidney cancer, lung cancer, Meningioma, myelodysplastic syndrome, nonfunctioning pituitary adenomas, Pituitary adenoma, prostate cancer, type 1 diabetes
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''ncR-PAR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289057 HSALNT0289057]
−
|[[NONHSAT102247]]
+
|[[LINC00662]]
−
|"NCRUPAR, ENSG00000225407"
+
|NA
−
|"non-protein coding RNA, upstream of F2R/PAR1"
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''NDM29''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289062 HSALNT0289062]
−
|[[lnc-C11orf16-1:1]]
+
|[[LINC00692]]
−
|29A
+
|NA
−
|"neuroblastoma differentiation marker 29 (Castelnuovo (2010), Pagano (2007))."
+
|NA
−
|neuroblastoma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''GNAS-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289064 HSALNT0289064]
−
|[[lnc-CTSZ-5:1]]
+
|[[LINC00705]]
−
|"GNAS antisense, GNAS1AS, NCRNA00075, NESP-AS, NESPAS, ""non-protein coding RNA 75"", SANG, ENSG00000235590"
+
|NA
−
|neuroendocrine secretory protein (Nesp) antisense.
+
|NA
−
|pseudohypoparathyroidism type Ib
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''NRON''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289067 HSALNT0289067]
−
|[[NONHSAT134764]]
+
|[[LINC00868]]
−
|ENSG00000253079
+
|C17orf52
−
|"non-protein coding RNA, repressor of NFAT"
+
|NA
−
|AIDS
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''NTT''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0130693 HSALNT0130693]
−
|[[NONHSAT115106]]
+
|[[LINC00996]]
−
|N/A
+
|NA
−
|noncoding transcript in T cells.
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''OTX2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289101 HSALNT0289101]
−
|[[lnc-C14orf101-5:1]]
+
|[[LINC01252]]
−
|"OTX2OS1, ENSG00000248550"
+
|NA
−
|OTX2 antisense RNA 1 (head to head)
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''PANDAR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289131 HSALNT0289131]
−
|[[lnc-CDKN1A-1:1]]
+
|[[LINC02135]]
−
|"P21 associated ncRNA DNA damage activated, PANDA antisense RNA, ENSG00000213500, PANDAR"
+
|NA
−
|promoter of CDKN1A antisense DNA damage activated RNA
+
|NA
−
|breast cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''PCGEM1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289193 HSALNT0289193]
−
|[[NONHSAT076153]]
+
|[[NIFK-AS1]]
−
|ENSG00000227418; PCAT9; LINC00071; NCRNA00071 lncRNA
+
|NA
−
|Prostate-specific transcript 1
+
|NA
−
|prostate cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LINC00853''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289244 HSALNT0289244]
−
|[[ENST00000429328.2]]
+
|[[SMG7-AS1]]
−
|"PDZK1IP1 antisense RNA 1 (non-protein coding), ""PDZK1IP1 antisense RNA 1 (tail to tail)"", PDZK1IP1-AS1 ,ENSG00000224805"
+
|DKFZP564C196
−
|long intergenic non-protein coding RNA 853
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''PRINS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0235326 HSALNT0235326]
−
|[[NONHSAT011777]]
+
|[[SNAI3-AS1]]
−
|ENSG00000238115
+
|MGC23284
−
|Psoriasis susceptibility-related RNA Gene Induced by Stress
+
|NA
−
|psoriasis
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''PTENP1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0215205 HSALNT0215205]
−
|[[NONHSAT130775]]
+
|[[SNHG10]]
−
|"PTENpg1, PTEN2, ENSG00000237984"
+
|C14orf62,FLJ40557,NCRNA00063,LINC00063
−
|PTEN Pseudogene 1
+
|NA
−
|prostate cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''MEG8''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289290 HSALNT0289290]
−
|[[ENST00000553584.1]]
+
|[[ZNF205-AS1]]
−
|"Bsr, ""Imprinted RNA near Meg3/Gtl2"", Irm, LINC00024, ""long intergenic non-protein coding RNA 24"", NCRNA00024, ""non-protein coding RNA 24"", Rian, ""RNA Imprinted and Accumulated in Nucleus"", ENSG00000258399"
+
|MGC3771
−
|Rian: RNA Imprinted and Accumulated in Nucleus;Irm: Imprinted RNA near Meg3/Gtl2;MEG8: Maternally expressed gene 8
+
|NA
−
|Prader-Willi/Angelman syndrome
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LINC00599''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289294 HSALNT0289294]
−
|[[lnc-TNKS-1:1]]
+
|[[LINC00260]]
−
|"retinal non-coding RNA 3, Rncr3, ENSG00000253230"
+
|C1orf217,NCRNA00260,MGC5457
−
|"Retinal noncoding RNA 3, long intergenic non-protein coding RNA 599"
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''FAS-AS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289295 HSALNT0289295]
−
|[[NONHSAT015489]]
+
|[[LINC00337]]
−
|"SAF, ENSG00000026103"
+
|C1orf211,NCRNA00337,MGC40168
−
|FAS antisense RNA 1
+
|NA
−
|B-cell lymphoma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''ATXN8OS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289298 HSALNT0289298]
−
|[[NONHSAT034251]]
+
|[[WAC-AS1]]
−
|"NCRNA00003, ""non-protein coding RNA 3"", ATXN8OS, KLHL1AS, SCA8, ENSG00000230223"
+
|NA
−
|Spinocerebellar ataxia 8 (SCA8) RNA;KLHL1AS: kelch-like 1 (Drosophila) antisense;ATXN8OS: ataxin 8 opposite strand
+
|NA
−
|human spinocerebellar ataxia type 8,Spinocerebellar ataxia type 8
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''SNHG1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289299 HSALNT0289299]
−
|[[NONHSAT021826]]
+
|[[LINC00839]]
−
|"UHG, ENSG00000255717"
+
|NA
−
|SNHG1:Small nucleolar RNA host gene 1;UHG: U22 host gene.
+
|NA
−
|gastric cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''SNHG3''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289303 HSALNT0289303]
−
|[[lnc-OR10H5-1:1]]
+
|[[LINC00612]]
−
|"U17HG, linc1343, ENSG00000242125"
+
|C12orf33,MGC40170,FLJ41814
−
|Small nucleolar RNA host gene 3
+
|NA
−
|Alzheimer's disease
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''SNHG4''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289312 HSALNT0289312]
−
|[[NONHSAT104072]]
+
|[[LINC00663]]
−
|"U19H, ENSG00000200959"
+
|MGC39821
−
|Small nucleolar RNA host gene 4
+
|NA
−
|myelodysplastic syndrome
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''SNHG5''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289320 HSALNT0289320]
−
|[[NONHSAT054526]]
+
|[[LINC00494]]
−
|"U50HG, ENSG00000203875"
+
|NA
−
|Small nucleolar RNA host gene 5
+
|NA
−
|lymphoma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''SNHG6''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289330 HSALNT0289330]
−
|[[lnc-TCF24-2:3]]
+
|[[LINC01019]]
−
|"U87HG, ENSG00000245910"
+
|NA
−
|Small nucleolar RNA host gene 6
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''SPRY4-IT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289333 HSALNT0289333]
−
|[[lnc-NDFIP1-3:1]]
+
|[[LINC00265]]
−
|"AK024556, ENSG00000274721"
+
|NCRNA00265,NCRNA00265-1
−
|SPRY4 intronic transcript 1 (non-protein coding)
+
|NA
−
|melanoma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''SRA''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289334 HSALNT0289334]
−
|[[lnc-SRA1-1:1]]
+
|[[LINC00689]]
−
|"SRA1, ENSG00000213523"
+
|NA
−
|Steroid receptor RNA Activator
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''TEA-ncRNAs''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289337 HSALNT0289337]
−
|[[NONHSAT035776]]
+
|[[LINC01591]]
−
|ENSG00000251002
+
|NA
−
|T early alpha
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''IFNG-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289340 HSALNT0289340]
−
|[[ENST00000538665.1]]
+
|[[LINC01501]]
−
|"LincR-Ifng-3'AS, NEST, "Theiler's murine encephalomyelitis virus persistence candidate gene 1", Tmevpg1, ENSG00000255733"
+
|NA
−
|IFNG antisense RNA 1
+
|NA
−
|multiple sclerosis
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''TncRNA''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289346 HSALNT0289346]
−
|[[NONHSAT022116]]
+
|[[LINC01560]]
−
|TSU
+
|CXorf24
−
|TncRNA: trophoblast noncoding RNA; TSU: trophoblast STAT utron (untranslated region of an mRNA).
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''TUG1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289352 HSALNT0289352]
−
|[[NONHSAT084827]]
+
|[[LINC01959]]
−
|ENSG00000253352
+
|NA
−
|taurine up-regulated gene 1
+
|NA
−
|B-cell neoplasms, bladder cancer, Huntington's disease, non-small cell lung cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''UCA1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289353 HSALNT0289353]
−
|[[lnc-OR10H5-1:1]]
+
|[[LINC02175]]
−
|"UCA1a, CUDR, UCAT1, LINC00178, NCRNA00178, GCAP2, GUCA1B, GUCA2, RP48, ENSG00000214049"
+
|NA
−
|urothelial cancer associated 1 (non-protein coding)
+
|NA
−
|bladder cancer, oral squamous cell carcinoma, pancreaticobiliary maljunction, squamous carcinoma,  tongue squamous cell carcinomas
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''KCNIP4-IT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289354 HSALNT0289354]
−
|[[NONHSAT095745]]
+
|[[LINC02209]]
−
|"non coding transcript UM9(5), UM9-5"
+
|FAM183CP
−
|KCNIP4 intronic transcript 1 (non-protein coding)
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''WT1-AS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289359 HSALNT0289359]
−
|[[lnc-EIF3M-1:1]]
+
|[[LINGO1-AS1]]
−
|"WIT1, ENSG00000183242"
+
|NA
−
|WT1 (Wilms' tumor 1) antisense transcript
+
|NA
−
|gastric cancer, hepatocellular carcinoma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''XIST''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289362 HSALNT0289362]
−
|[[NONHSAT137541]]
+
|[[MAFG-AS1]]
−
|ENSG00000229807
+
|MAFG-DT
−
|X inactive-specific transcript
+
|NA
−
|bladder cancer, breast cancer, Klinefelter's syndrome, testicular cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''ZEB2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289373 HSALNT0289373]
−
|[[NONHSAT074775]]
+
|[[MORF4L2-AS1]]
−
|"Zeb2NAT, ENSG00000238057"
+
|NA
−
|Zeb2 natural antisense transcript
+
|NA
−
|bladder cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''ZFAS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289381 HSALNT0289381]
−
|[[NONHSAT080206]]
+
|[[NPHP3-AS1]]
−
|"Znfx1 antisense, 1500012F01Rik, NCRNA00275, ENSG00000177410"
+
|NCRNA00119
−
|ZNFX1 antisense RNA 1
+
|NA
−
|breast cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''Zfhx2as''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289385 HSALNT0289385]
−
|[[ENST00000554403.1]]
+
|[[PAXIP1-AS1]]
−
|"Zfh-5AS, ENSG00000157306"
+
|NA
−
|"zinc finger homeobox 2, antisense"
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''TMEM161B-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289413 HSALNT0289413]
−
|[[lnc-RASA1-3:23]],
+
|[[TOLLIP-AS1]]
−
[[lnc-RASA1-3:25]]
+
|NA
−
|"AK082072,linc-POLR3G-8, ENSG00000247828"
+
|NA
−
|TMEM161B antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|NA
 
|-
 
|-
−
|''Alpha 250/ Alpha 280''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289416 HSALNT0289416]
−
|[[NONHSAT104559]],
+
|[[LINC00311]]
−
[[lnc-NDST1-1:2]]
+
|TMEM148,NCRNA00311,MGC22001
−
|N/A
+
|NA
−
|N/A
+
|NA
−
|_
+
|NA
 +
|NA
 
|-
 
|-
−
|''CDKN2B-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289422 HSALNT0289422]
−
|[[NONHSAT130421]],
+
|[[ZNF252P-AS1]]
−
[[lnc-C9orf53-2:1]]
+
|C8orf77
−
|"ANRIL, p15AS, ENSG00000240498"
+
|NA
−
|CDKN2B antisense RNA 1
+
|NA
−
|abdominal aortic aneurysm,acute lymphoblastic leukemia,basal cell carcinoma,breast cancer,cardiovascular disease,coronary artery disease,coronary heart disease,Diabetes,endometriosis,Esophageal squamous cell cancer,gastric cancer,glioma,hereditary cutaneous malignant melanoma,intracranial aneurism,ischemic stroke,melanoma,myocardial infarction,nasopharyngeal carcinoma,neural system tumors syndrome,Neurofibromatosis type 1,periodontitis,prostate cancer,
+
|NA
 +
|NA
 
|-
 
|-
−
|''BACE1-AS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289423 HSALNT0289423]
−
|[[NONHSAT024403]],[[lnc-RNF214-1:2]]
+
|[[ZNF436-AS1]]
−
|"BACE1AS,NCRNA00177; FJ573250"
+
|C1orf213,FLJ90508
−
|BACE1 antisense RNA
+
|NA
−
|Alzheimer's disease,
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''Beta-globin transcripts''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289429 HSALNT0289429]
−
|[[NONHSAT017676]],
+
|[[BFSP2-AS1]]
−
[[NONHSAT017675]],
+
|MGC2848
−
[[NONHSAT017674]]
+
|NA
−
|N/A
+
|NA
−
|N/A
+
|NA
−
|_
+
|NA
 
|-
 
|-
−
|''LINC00581''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289432 HSALNT0289432]
−
|[[lnc-PRL-6:2]],
+
|[[CTBP1-DT]]
−
[[lnc-PRL-6:1]]
+
|C4orf42,CTBP1-AS1,CTBP1-DT,MGC21675
−
|"BX118339,Hs.112750, linc-MBOAT1-4: TCONS_00012107, linc-MBOAT1-4: TCONS_00012678"
+
|NA
−
|long intergenic non-protein coding RNA 581
+
|NA
−
|West Syndrome
+
|NA
 +
|NA
 
|-
 
|-
−
|''CAR Intergenic 10''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289436 HSALNT0289436]
−
|[[NONHSAT016928]],
+
|[[EXOC3-AS1]]
−
[[lnc-FANK1-3:1]]
+
|C5orf55
−
|"Intergenic10, CR611911, AK055628"
+
|NA
−
|Chromatin Associated RNA 10
+
|NA
−
|_
+
|NA
 +
|NA
 
|-
 
|-
−
|''DIO3OS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289441 HSALNT0289441]
−
|[[NONHSAT040032]],
+
|[[HCG27]]
−
[[NONHSAT040039]]
+
|bPG299F13.9,bCX101P6.9,bQB115I13.2,FLJ40123
−
|"DIO3-AS1, NCRNA00041, ""non-protein coding RNA 41"", ENSG00000258498"
+
|NA
−
|DIO3 opposite strand/antisense RNA (head to head)
+
|NA
−
|_
+
|NA
 +
|NA
 
|-
 
|-
−
|''PCAT6''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289450 HSALNT0289450]
−
|[[PCAT6]]
+
|[[BAALC-AS2]]
−
|"Noncoding RNA activating2: ncRNA-a2, KDM5B antisense RNA 1 (KDM5B-AS1),, ENSG00000228288"
+
|C8orf56,BAALCOS,MGC39526
−
|N/A
+
|NA
−
|prostate cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LINC00570''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289453 HSALNT0289453]
−
|[[ENST00000417473.2]]
+
|[[FAM87A]]
−
|"KDM5BAS1, ncRNA-a2, onco-lncRNA-96, PCAN-R1, ""prostate cancer-associated noncoding RNA 1"",ENSG00000224177,"
+
|NA
−
|prostate cancer associated transcript 6 (non-protein coding)
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289459 HSALNT0289459]
 +
|[[JMJD1C-AS1]]
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289465 HSALNT0289465]
 +
|[[ATP2B1-AS1]]
 +
|LINC00936
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''NEAT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289466 HSALNT0289466]
−
|[[ENST00000501122.2]],
+
|[[CEP83-AS1]]
−
[[NONHSAT022111]]
+
|CEP83-DT
−
|"MEN epsilon/beta, VINC, TncRNA, linc1317, ENSG00000245532"
+
|NA
−
|Nuclear enriched abundant transcript 1.
+
|NA
−
|infertility
+
|NA
 +
|NA
 
|-
 
|-
−
|''ST7OT''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289470 HSALNT0289470]
−
|[[NONHSAT122926]],
+
|[[HEXA-AS1]]
−
[[NONHSAT122918]],
+
|C15orf34,FLJ13315
−
[[NONHSAT122914]],
+
|NA
−
[[NONHSAT122932]]
+
|NA
−
|"ST7OT1, ST7OT2, ST7OT3, ST7OT4, ST7AS1, ST7AS2, ST7AS3, ST7AS4, ENSG00000214188"
+
|NA
−
|N/A
+
|NA
−
|_
 
 
|-
 
|-
−
|''snaR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289487 HSALNT0289487]
−
|[[lnc-BSPH1-1:1]],[[lnc-BSPH1-2:1]]
+
|[[BIN3-IT1]]
−
|small NF90-associated RNAs
+
|FLJ14107
−
|small NF90-associated RNAs
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''Y RNAs''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289490 HSALNT0289490]
−
|[[lnc-PDIA4-1:1]]
+
|[[CSNK1G2-AS1]]
−
|N/A
+
|C19orf34,MGC39696
−
|N/A
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''PR antisense transcripts''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289508 HSALNT0289508]
−
|[[NONHSAT023851]]
+
|[[LINC00634]]
−
|N/A
+
|NA
−
|N/A
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''FAM3D-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289510 HSALNT0289510]
−
|[[FAM3D-AS1]]
+
|[[LINC00685]]
−
|lnc-KCTD6-3
+
|CXYorf10,NCRNA00107,PPP2R3B-AS1,OTTHUMT00000055574
−
|FAM3D antisense RNA 1
+
|NA
−
|head and neck squamous cell carcinoma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''SHANK2-AS3''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289515 HSALNT0289515]
 
|[[SHANK2-AS3]]
 
|[[SHANK2-AS3]]
−
|N/A
+
|C11orf76
−
|SHANK2 antisense RNA 3
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''AATBC''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290073 HSALNT0290073]
−
|[[AATBC]]
+
|[[NCBP2-AS2]]
−
|N/A
+
|NA
−
|apoptosis associated transcript in bladder cancer
+
|NA
−
|bladder cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''ABHD11-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289502 HSALNT0289502]
−
|[[ABHD11-AS1]]
+
|[[NONHSAT095745]]
−
|NCRNA00035
+
|NCRNA00099,UM9-5
−
|ABHD11 antisense RNA 1 (tail to tail)
+
|NA
−
|gastric cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''ABHD15-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289856 HSALNT0289856]
−
|[[ABHD15-AS1]]
+
|[[GTSCR1]]
−
|"linc-TP53I13, lnc-TP53I13"
+
|NA
−
|ABHD15 antisense RNA 1
+
|NA
−
|cardiometabolic diseases
+
|pathogenic process
 +
|Gilles de la Tourette syndrome
 +
|Mental Disorders;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
 
|-
 
|-
−
|''ACTA2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289325 HSALNT0289325]
−
|[[ACTA2-AS1]]
+
|[[LINC00272]]
−
|"uc001kfo.1, ZXF1"
+
|C1orf120,NCRNA00272,RP1-223H12.3
−
|ACTA2 antisense RNA 1
+
|NA
−
|lung adenocarcinoma
+
|pathogenic process
 +
|prostate cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''ADAMTS9-AS2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288512 HSALNT0288512]
−
|[[ADAMTS9-AS2]]
+
|[[TTTY9B]]
−
|N/A
+
|NCRNA00132
−
|ADAMTS9 antisense RNA 2
+
|NA
−
|glioma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''ADORA2A-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290155 HSALNT0290155]
−
|[[ADORA2A-AS1]]
+
|[[Prion-associated RNAs]]
−
|FLJ34651
+
|NA
−
|ADORA2A antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|prion disease
 +
|Nervous System Diseases
 
|-
 
|-
−
|''AFAP1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289444 HSALNT0289444]
−
|[[AFAP1-AS1]]
+
|[[BLACE]]
−
|MGC10981
+
|NA
−
|AFAP1 antisense RNA 1
+
|NA
−
|Barrett's esophagus and esophageal adenocarcinoma
+
|pathogenic process
 +
|acute B lymphoblastic leukemias
 +
|Hemic and Lymphatic Diseases
 
|-
 
|-
−
|''AGAP2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0060411 HSALNT0060411]
−
|[[AGAP2-AS1]]
+
|[[H1FX-AS1]]
−
|"LOC100130776, PUNISHER"
+
|C3orf47,FLJ34151
−
|AGAP2 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''Alpha 250/Alpha 280''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0186668 HSALNT0186668]
−
|[[NONHSAT104559]],[[lnc-NDST1-1:2]]
+
|[[LINC00477]]
−
|N/A
+
|C12orf67,FLJ32894,FAM191B
−
|N/A
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''ANP32A-IT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0275096 HSALNT0275096]
−
|[[ANP32A-IT1]]
+
|[[LINC00528]]
−
|"FLJ11722, HsT18971"
+
|C22orf37,FLJ40542
−
|ANP32A intronic transcript 1
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''ARRDC1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0287824 HSALNT0287824]
−
|[[ARRDC1-AS1]]
+
|[[ASMTL-AS1]]
−
|N/A
+
|CXYorf2,NCRNA00105,ASMTLAS,ASMTL-AS,FLJ13330
−
|ARRDC1 antisense RNA 1
+
|NA
−
|breast cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''ASAP1-IT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288887 HSALNT0288887]
−
|[[ASAP1-IT1]]
+
|[[ANP32A-IT1]]
−
|"HSPC054, NCRNA00050, ASAP1IT, ASAP1-IT"
+
|C15orf28,NCRNA00321,FLJ11722,HsT18971
−
|ASAP1 intronic transcript 1
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''ASMTL-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289396 HSALNT0289396]
−
|[[ASMTL-AS1]]
+
|[[RUSC1-AS1]]
−
|FLJ13330
+
|C1orf104,FLJ35976
−
|ASMTL antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''ATP1A1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0084628 HSALNT0084628]
−
|[[ATP1A1-AS1]]
+
|[[LINC01194]]
−
|MGC16179
+
|CT49,TAG
−
|ATP1A1 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|melanoma
 +
|Neoplasms
 
|-
 
|-
−
|''B3GALT5-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289468 HSALNT0289468]
−
|[[B3GALT5-AS1]]
+
|[[NONHSAT040032]]
−
|N/A
+
|C14orf134,NCRNA00041,DIO3-AS1,NONHSAT040032,NONHSAT040039,BC111049
−
|B3GALT5 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''B4GALT1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0121060 HSALNT0121060]
−
|[[B4GALT1-AS1]]
+
|[[NPSR1-AS1]]
−
|N/A
+
|AAA1,IMAGE:4827585
−
|B4GALT1 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''BAALC-AS2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0074370 HSALNT0074370]
−
|[[BAALC-AS2]]
+
|[[LINC00575]]
−
|MGC39526
+
|C4orf11
−
|BAALC antisense RNA 2
+
|NA
−
|_
+
|pathogenic process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''BCAR4''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0137345 HSALNT0137345]
−
|[[BCAR4]]
+
|[[LINC01602]]
−
|N/A
+
|T1560
−
|breast cancer anti-estrogen resistance 4 (non-protein coding)
+
|NA
−
|breast cancer
+
|pathogenic process
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289433 HSALNT0289433]
 +
|[[FAM13A-AS1]]
 +
|FAM13A1OS,FAM13AOS,NCRNA00039
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289186 HSALNT0289186]
 +
|[[MIRLET7DHG]]
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''BFSP2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0155254 HSALNT0155254]
−
|[[BFSP2-AS1]]
+
|[[MIR181A2HG]]
−
|MGC2848
+
|NA
−
|BFSP2 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''BGLT3''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289283 HSALNT0289283]
−
|[[BGLT3]]
+
|[[WDFY3-AS2]]
−
|"LINC01083, BGL3, lncRNA-BGL3"
+
|C4orf12,NCRNA00247,FBI4
−
|beta globin locus transcript 3 (non-protein coding)
+
|NA
−
|Bcr-Abl-positive leukemia
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''BIN3-IT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0154555 HSALNT0154555]
−
|[[BIN3-IT1]]
+
|[[PAPPA-AS1]]
−
|FLJ14107
+
|PAPPAS,PAPPA-AS,DIPAS,TAF4B,TAF2C2,TAFII105,NCRNA00156
−
|BIN3 intronic transcript 1
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''BIRC6-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0136307 HSALNT0136307]
−
|[[BIRC6-AS1]]
+
|[[LINC00293]]
−
|N/A
+
|BEYLA
−
|BIRC6 antisense RNA 1
+
|NA
−
|_
+
|developmental process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''BIRC6-AS2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0030983 HSALNT0030983]
−
|[[BIRC6-AS2]]
+
|[[SIX3-AS1]]
−
|megamind
+
|SIX3OS
−
|BIRC6 antisense RNA 2
+
|NA
−
|_
+
|developmental process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''BISPR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0211503 HSALNT0211503]
−
|[[BISPR]]
+
|[[Lnc-C14orf101-5:1]]
−
|N/A
+
|OTX2OS1
−
|BST2 interferon stimulated positive regulator (non-protein coding)
+
|NA
−
|_
+
|developmental process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''BOK-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0063422 HSALNT0063422]
−
|[[BOK-AS1]]
+
|[[LINC01192]]
−
|"NCRNA00151, NAToB"
+
|CT64
−
|BOK antisense RNA 1
+
|NA
−
|testicular cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''BRWD1-AS2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0217123 HSALNT0217123]
−
|[[BRWD1-AS2]]
+
|[[LINC01193]]
−
|N/A
+
|CT60,LOC348120
−
|BRWD1 antisense RNA 2
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''C1QTNF9B-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289664 HSALNT0289664]
 
|[[C1QTNF9B-AS1]]
 
|[[C1QTNF9B-AS1]]
 
|PCOTH
 
|PCOTH
−
|C1QTNF9B antisense RNA 1
+
|NA
 +
|pathogenic process
 
|prostate cancer
 
|prostate cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''C21orf91-OT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289623 HSALNT0289623]
−
|[[C21orf91-OT1]]
+
|[[ATP6V1G2-DDX39B]]
−
|D21S2089E
+
|NA
−
|C21orf91 overlapping transcript 1
+
|NA
−
|_
+
|pathogenic process
 +
|dilated cardiomyopathy
 +
|Cardiovascular Diseases
 
|-
 
|-
−
|''C5orf66-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289498 HSALNT0289498]
−
|[[C5orf66-AS1]]
+
|[[FAM226B]]
−
|"CTC-276P9.1, Epist"
+
|CXorf50B,NCRNA00246B,LINC00246B
−
|C5orf66 antisense RNA 1
+
|NA
−
|esophageal squamous cell carcinoma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''C5orf66-AS2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289321 HSALNT0289321]
−
|[[C5orf66-AS2]]
+
|[[LINC00163]]
−
|N/A
+
|C21orf134,NCRNA00163,NLC1-A,NLC1A
−
|C5orf66 antisense RNA 2
+
|NA
−
|_
+
|pathogenic process
 +
|narcolepsy
 +
|Mental Disorders;Nervous System Diseases
 
|-
 
|-
−
|''C8orf34-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289505 HSALNT0289505]
−
|[[C8orf34-AS1]]
+
|[[LINC00165]]
−
|N/A
+
|C21orf135,NCRNA00165,NLC1-B
−
|C8orf34 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''CACNA1G-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290297 HSALNT0290297]
−
|[[CACNA1G-AS1]]
+
|[[NONHSAT035776]]
−
|N/A
+
|ENSG00000251002
−
|CACNA1G antisense RNA 1
+
|NA
−
| keloid
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''CAPN10-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0274212 HSALNT0274212]
−
|[[CAPN10-AS1]]
+
|[[LINC00322]]
−
|locus959
+
|C21orf136,NCRNA00322,FLJ16545
−
|CAPN10 antisense RNA 1 (head to head)
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''CARD8-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289741 HSALNT0289741]
−
|[[CARD8-AS1]]
+
|[[NONHSAT102417]]
−
|LOC100505812
+
|DHFR minor transcript 5'-UTR,ENSG00000228716,NONHSAT102417
−
|CARD8 antisense RNA 1
+
|transcriptional regulation
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''CARMN''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289527 HSALNT0289527]
−
|[[CARMN]]
+
|[[NONHSAT128494]]
−
|CARMEN
+
|ncRNA 21A,NONHSAT128494
−
|cardiac mesoderm enhancer-associated non-coding RNA
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''CASC11''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289409 HSALNT0289409]
−
|[[CASC11]]
+
|[[TLX1NB]]
−
|"TCONSN/A00014535, LINC00990, CARLo-7"
+
|TD1,TDI,APT-B7
−
|cancer susceptibility candidate 11 (non-protein coding)
+
|NA
−
|colorectal cancer
+
|pathogenic process
 +
|leukemogenesis
 +
|Hemic and Lymphatic Diseases
 
|-
 
|-
−
|''CASC15''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289662 HSALNT0289662]
−
|[[CASC15]]
+
|[[C15orf2]]
−
|N/A
+
|NA
−
|cancer susceptibility candidate 15 (non-protein coding)
+
|NA
−
|metastatic melanoma
+
|pathogenic process
 +
|Angelman syndrome
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
 
|-
 
|-
−
|''CASC19''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290097 HSALNT0290097]
−
|[[CASC19]]
+
|[[NPAP1]]
−
|CARLo-6
+
|NA
−
|cancer susceptibility candidate 19 (non-protein coding)
+
|NA
−
|prostate cancer
+
|pathogenic process
 +
|Angelman syndrome
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
 
|-
 
|-
−
|''CASC2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0217406 HSALNT0217406]
−
|[[CASC2]]
+
|[[NONHSAT040875]]
−
|N/A
+
|NCRNA00199
−
|cancer susceptibility candidate 2 (non-protein coding)
+
|NA
−
|colorectal cancer
+
|pathogenic process
 +
|Prader-Willi syndrome
 +
|Nutritional and Metabolic Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
 
|-
 
|-
−
|''CASC21''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289227 HSALNT0289227]
−
|[[CASC21]]
+
|[[NONHSAT040920]]
−
|CARLo-2
+
|NCRNA00198
−
|cancer susceptibility candidate 21 (non-protein coding)
+
|NA
−
|_
+
|pathogenic process
 +
|Prader-Willi syndrome
 +
|Nutritional and Metabolic Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0262816 HSALNT0262816]
 +
|[[MIMT1]]
 +
|MIM1,NCRNA00067,LINC00067
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''CASC22''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289180 HSALNT0289180]
−
|[[CASC22]]
+
|[[MIR34AHG]]
−
|"TCONSN/A00024290, LincRNA-ENST00000515084"
+
|NA
−
|cancer susceptibility candidate 22 (non-protein coding)
+
|NA
−
|breast cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''CASC9''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289357 HSALNT0289357]
−
|[[CASC9]]
+
|[[LINC02570]]
−
|"LINC00981, ESCCAL-1"
+
|XXbac-BPG27H4.8
−
|cancer susceptibility candidate 9 (non-protein coding)
+
|NA
−
|predicted esophageal squamous cell carcinoma
+
|pathogenic process
 +
|MHC-associated diseases
 +
|Immune System Diseases
 
|-
 
|-
−
|''CBR3-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290177 HSALNT0290177]
−
|[[CBR3-AS1]]
+
|[[RNY1]]
−
|PlncRNA-1
+
|NA
−
|CBR3 antisense RNA 1
+
|NA
−
|esophageal squamous carcinoma cell
+
|pathogenic process
 +
|cervix cancer;prostate cancer;colorectal cancer;bladder cancer;kidney cancer;lung cancer
 +
|Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases
 
|-
 
|-
−
|''CCDC18-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289378 HSALNT0289378]
−
|[[CCDC18-AS1]]
+
|[[NKX2-2-AS1]]
−
|ENST00000440778.1
+
|NKX2-2AS
−
|CCDC18 antisense RNA 1
+
|transcriptional regulation
−
|Adolescent Idiopathic Scoliosis
+
|pathogenic process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''CCDC26''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290151 HSALNT0290151]
−
|[[CCDC26]]
+
|[[NONHSAT023851]]
−
|"MGC27434, RAM"
+
|FJ515872.1,NONHSAT023851
−
|CCDC26 long non-coding RNA
+
|transcriptional regulation
−
|glioma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''CCEPR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289607 HSALNT0289607]
−
|[[CCEPR]]
+
|[[Anti-NOS2A]]
−
|CCHE1
+
|NA
−
|cervical carcinoma expressed PCNA regulatory lncRNA
+
|NA
−
|cervical cancer
+
|pathogenic process
 +
|meningioma;glioblastoma
 +
|Neoplasms;Nervous System Diseases
 
|-
 
|-
−
|''CDKN1A-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289687 HSALNT0289687]
 
|[[CDKN1A-AS1]]
 
|[[CDKN1A-AS1]]
 
|p21NAT
 
|p21NAT
−
|CDKN1A antisense RNA 1
+
|transcriptional regulation
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''CDR1-AS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0116668 HSALNT0116668]
−
|[[CDR1-AS]]
+
|[[RPS6KA2-AS1]]
−
|"CDR1NAT, ciRS-7, CDR1as"
+
|NA
−
|CDR1 antisense RNA
+
|NA
−
|_
+
|pathogenic process
 +
|breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''CDRT7''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289384 HSALNT0289384]
−
|[[CDRT7]]
+
|[[PAPPA-AS2]]
−
|"NCRNA00025, LINC00025"
+
|AGU1
−
|CMT1A duplicated region transcript 7 (non-protein coding)
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''CDRT8''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0262802 HSALNT0262802]
−
|[[CDRT8]]
+
|[[ZIM2-AS1]]
−
|N/A
+
|ZIM2as
−
|CMT1A duplicated region transcript 8
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''CECR3''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289824 HSALNT0289824]
−
|[[CECR3]]
+
|[[Lnc-DLX5-3:1]]
−
|N/A
+
|Evf-2,Dlx6as1,Dlx6os1,ENSG00000231764, ENST00000430027.2,lnc-DLX5-3:1
−
|"cat eye syndrome chromosome region, candidate 3 (non-protein coding)"
+
|transcriptional regulation
−
|cat eye syndrome
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''CECR5-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289481 HSALNT0289481]
−
|[[CECR5-AS1]]
+
|[[ADORA2A-AS1]]
−
|NCRNA00017
+
|C22orf45,FLJ34651
−
|CECR5 antisense RNA 1
+
|NA
−
|cat eye syndrome
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''CECR7''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290146 HSALNT0290146]
−
|[[CECR7]]
+
|[[POU5F1P4]]
−
|SAHL1
+
|NA
−
|"cat eye syndrome chromosome region, candidate 7 (non-protein coding)"
+
|NA
−
|cat eye syndrome
+
|pathogenic process
 +
|prostate cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''CECR9''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290033 HSALNT0290033]
−
|[[CECR9]]
+
|[[LSINCT1]]
−
|N/A
+
|NA
−
|"cat eye syndrome chromosome region, candidate 9 (non-protein coding)"
+
|NA
−
|cat eye syndrome
+
|pathogenic process
 +
|lung cancer;breast cancer
 +
|Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''CEP83-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290034 HSALNT0290034]
−
|[[CEP83-AS1]]
+
|[[LSINCT10]]
−
|N/A
+
|NA
−
|CEP83 antisense RNA 1 (head to head)
+
|NA
−
|_
+
|pathogenic process
 +
|lung cancer;breast cancer
 +
|Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''CIRBP-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290035 HSALNT0290035]
−
|[[CIRBP-AS1]]
+
|[[LSINCT11]]
−
|MGC39338
+
|NA
−
|CIRBP antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|lung cancer;breast cancer
 +
|Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''CLRN1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290036 HSALNT0290036]
−
|[[CLRN1-AS1]]
+
|[[LSINCT12]]
−
|UCRP
+
|NA
−
|CLRN1 antisense RNA 1
+
|NA
−
|Usher syndrome type 3
+
|pathogenic process
 +
|lung cancer;breast cancer
 +
|Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''COPG2IT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290037 HSALNT0290037]
−
|[[COPG2IT1]]
+
|[[LSINCT2]]
−
|"CIT1, NCRNA00170, COPG2AS"
+
|NA
−
|COPG2 imprinted transcript 1 (non-protein coding)
+
|NA
−
|_
+
|pathogenic process
 +
|lung cancer;breast cancer
 +
|Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''CPS1-IT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290038 HSALNT0290038]
−
|[[CPS1-IT1]]
+
|[[LSINCT3]]
−
|"PRO0132, CPS1-IT"
+
|NA
−
|CPS1 intronic transcript 1
+
|NA
−
|_
+
|pathogenic process
 +
|lung cancer;breast cancer
 +
|Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''CSNK1G2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290039 HSALNT0290039]
−
|[[CSNK1G2-AS1]]
+
|[[LSINCT4]]
−
|MGC39696
+
|NA
−
|CSNK1G2 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|lung cancer;breast cancer
 +
|Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''CSTF3-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290041 HSALNT0290041]
−
|[[CSTF3-AS1]]
+
|[[LSINCT6]]
−
|N/A
+
|NA
−
|CSTF3 antisense RNA 1 (head to head)
+
|NA
−
|_
+
|pathogenic process
 +
|lung cancer;breast cancer
 +
|Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''CTBP1-AS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290042 HSALNT0290042]
−
|[[CTBP1-AS]]
+
|[[LSINCT7]]
−
|PCAT10
+
|NA
−
|CTBP1 antisense RNA
+
|NA
−
| prostate cancer
+
|pathogenic process
 +
|lung cancer;breast cancer
 +
|Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''CTBP1-AS2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290043 HSALNT0290043]
−
|[[CTBP1-AS2]]
+
|[[LSINCT8]]
−
|MGC21675
+
|NA
−
|CTBP1 antisense RNA 2 (head to head)
+
|NA
−
|_
+
|pathogenic process
 +
|lung cancer;breast cancer
 +
|Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''CYP1B1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290044 HSALNT0290044]
−
|[[CYP1B1-AS1]]
+
|[[LSINCT9]]
−
|MGC34824
+
|NA
−
|CYP1B1 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|lung cancer;breast cancer
 +
|Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''CYP51A1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289676 HSALNT0289676]
−
|[[CYP51A1-AS1]]
+
|[[NONHSAT016928]]
−
|"ENST00000453068, LRRD1-AS1"
+
|FLJ31066,NONHSAT016928,lnc-FANK1-3:1
−
|CYP51A1 antisense RNA 1
+
|transcriptional regulation
−
|renal cell carcinoma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''DACOR1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290032 HSALNT0290032]
−
|[[DACOR1]]
+
|[[LRRC3DN]]
−
|TCONSN/A00023265
+
|C21orf30,DKFZP434C128
−
|DNMT1-associated colon cancer repressed lncRNA 1
+
|transcriptional regulation
−
|colon cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''DANT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0266984 HSALNT0266984]
−
|[[DANT1]]
+
|[[SNHG11]]
−
|N/A
+
|C20orf198,LINC00101,NCRNA00101
−
|"DXZ4 associated non-coding transcript 1, proximal"
+
|NA
−
|_
+
|pathogenic process
 +
|obesity
 +
|Nutritional and Metabolic Diseases
 
|-
 
|-
−
|''DANT2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289880 HSALNT0289880]
−
|[[DANT2]]
+
|[[NONHSAT113225]]
−
|N/A
+
|NONHSAT113225,ENSG00000220635
−
|"DXZ4 associated non-coding transcript 2, distal"
+
|ceRNA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''DAOA-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0006368 HSALNT0006368]
−
|[[DAOA-AS1]]
+
|[[ENST00000444042.2]]
−
|G30
+
|ncRNA-a3
−
|DAOA antisense RNA 1
+
|transcriptional regulation
−
|bipolar illness,schizophrenia
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''DAPK1-IT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0027470 HSALNT0027470]
−
|[[DAPK1-IT1]]
+
|[[ENST00000417473.2]]
−
|N/A
+
|ncRNA-a5
−
|DAPK1 intronic transcript 1
+
|transcriptional regulation
−
| pancreatic cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''DBH-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289066 HSALNT0289066]
−
|[[DBH-AS1]]
+
|[[ENST00000429328.2]]
−
|BPR
+
|PDZK1IP1-AS1,ncRNA-a4
−
|DBH antisense RNA 1
+
|transcriptional regulation
−
|hepatocellular carcinoma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''DGCR10''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289936 HSALNT0289936]
−
|[[DGCR10]]
+
|[[NONHSAT059436]]
−
|DGS-B
+
|ROR,lincRNA-ST8SIA3,ENSG00000258609,NONHSAT059436
−
|DiGeorge syndrome critical region gene 10 (non-protein coding)
+
|NA
−
|DiGeorge syndrome
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''DGCR11''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289705 HSALNT0289705]
−
|[[DGCR11]]
+
|[[CHL1-AS2]]
−
|DGS-D
+
|NA
−
|DiGeorge syndrome critical region gene 11 (non-protein coding)
+
|NA
−
|DiGeorge and velo-cardio-facial syndrome
+
|pathogenic process
 +
|adolescent idiopathic scoliosis
 +
|Musculoskeletal Diseases
 
|-
 
|-
−
|''DGCR12''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0076084 HSALNT0076084]
−
|[[DGCR12]]
+
|[[SEC24B-AS1]]
−
|DGS-E
+
|1/2-SBSRNA4
−
|DiGeorge syndrome critical region gene 12 (non-protein coding)
+
|siRNA
−
|DiGeorge and velo-cardio-facial syndrome
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''DGCR5''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290137 HSALNT0290137]
−
|[[DGCR5]]
+
|[[PDZRN3-AS1]]
−
|"NCRNA00037, LINC00037"
+
|NA
−
|DiGeorge syndrome critical region gene 5 (non-protein coding)
+
|NA
−
|DiGeorge syndrome
+
|pathogenic process
 +
|type 2 diabetes
 +
|Nutritional and Metabolic Diseases;Endocrine System Diseases
 
|-
 
|-
−
|''DGCR9''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290237 HSALNT0290237]
−
|[[DGCR9]]
+
|[[SCAANT1]]
−
|"DGS-A, POM121L5P"
+
|ATXN7-AS1
−
|DiGeorge syndrome critical region gene 9 (non-protein coding)
+
|transcriptional regulation
−
|DiGeorge syndrome
+
|pathogenic process
 +
|spinocerebellar ataxia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
 
|-
 
|-
−
|''DIAPH2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289594 HSALNT0289594]
−
|[[DIAPH2-AS1]]
+
|[[AK123790]]
−
|N/A
+
|NA
−
|DIAPH2 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|hepatocelluar cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''DISC1FP1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289911 HSALNT0289911]
−
|[[DISC1FP1]]
+
|[[LINC01451]]
−
|N/A
+
|NA
−
|DISC1 fusion partner 1 (non-protein coding)
+
|NA
−
|_
+
|pathogenic process
 +
|hepatocelluar cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''DLG2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290401 HSALNT0290401]
−
|[[DLG2-AS1]]
+
|[[ZNF350-AS1]]
−
|"PSZA11q14, SZ-1"
+
|NA
−
|DLG2 antisense RNA 1
+
|NA
−
|schizophrenia
+
|pathogenic process
 +
|hepatocelluar cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''DLGAP1-AS3''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289845 HSALNT0289845]
−
|[[DLGAP1-AS3]]
+
|[[GADD45G]]
−
|N/A
+
|NA
−
|DLGAP1 antisense RNA 3
+
|NA
−
|_
+
|pathogenic process
 +
|pituitary adenoma
 +
|Endocrine System Diseases;Neoplasms;Nervous System Diseases
 
|-
 
|-
−
|''DLX6-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289410 HSALNT0289410]
−
|[[DLX6-AS1]]
+
|[[Lnc-RASA1-3:23]]
−
|"FLJ34048, Evf-2"
+
|AK082072,linc-POLR3G-8,ENSG00000247828
−
|DLX6 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''DNM3OS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289736 HSALNT0289736]
−
|[[DNM3OS]]
+
|[[DAPK1]]
−
|"MIR199A2HG, DNM3-AS1"
+
|NA
−
|DNM3 opposite strand/antisense RNA
+
|NA
−
|Sézary syndrome
+
|pathogenic process
 +
|Pancreatic ductal adenocarcinoma
 +
|Neoplasms
 
|-
 
|-
−
|''DRAIC''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290048 HSALNT0290048]
−
|[[DRAIC]]
+
|[[MAP3K14]]
−
|N/A
+
|MAP3K14
−
|"downregulated RNA in cancer, inhibitor of cell invasion and migration"
+
|NA
−
|prostate cancer, bladder cancer, low-grade gliomas, lung adenocarcinoma, stomach adenocarcinoma, renal clear cell carcinoma, hepatocellular carcinoma, skin melanoma
+
|pathogenic process
 +
|Pancreatic ductal adenocarcinoma
 +
|Neoplasms
 
|-
 
|-
−
|''DSCR10''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290150 HSALNT0290150]
−
|[[DSCR10]]
+
|[[PPP3CB]]
−
|N/A
+
|NA
−
|Down syndrome critical region 10 (non-protein coding)
+
|NA
−
|_
+
|pathogenic process
 +
|Pancreatic ductal adenocarcinoma
 +
|Neoplasms
 
|-
 
|-
−
|''DSCR9''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0151531 HSALNT0151531]
−
|[[DSCR9]]
+
|[[DAPK1-IT1]]
−
|NCRNA00038
+
|NA
−
|Down syndrome critical region 9 (non-protein coding)
+
|NA
−
|_
+
|pathogenic process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''DUBR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288990 HSALNT0288990]
−
|[[DUBR]]
+
|[[GDNF-AS1]]
−
|N/A
+
|GDNFOS
−
|DPPA2 upstream binding RNA
+
|transcriptional regulation
−
|_
+
|pathogenic process
 +
|Alzheimer's disease
 +
|Mental Disorders;Nervous System Diseases
 
|-
 
|-
−
|''EGFR-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0029702 HSALNT0029702]
−
|[[EGFR-AS1]]
+
|[[BIRC6-AS2]]
−
|N/A
+
|megamind
−
|EGFR antisense RNA 1
+
|NA
−
|_
+
|developmental process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''ELFN1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0029692 HSALNT0029692]
−
|[[ELFN1-AS1]]
+
|[[BIRC6-AS1]]
−
|N/A
+
|NA
−
|ELFN1 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''ENTPD3-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289310 HSALNT0289310]
−
|[[ENTPD3-AS1]]
+
|[[LINC00854]]
−
|FLJ36665
+
|NA
−
|ENTPD3 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''EPB41L4A-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290332 HSALNT0290332]
−
|[[EPB41L4A-AS1]]
+
|[[Uc.73]]
−
|TIGA1
+
|NA
−
|EPB41L4A antisense RNA 1
+
|NA
−
|cancer
+
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''EPB41L4A-AS2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289841 HSALNT0289841]
−
|[[EPB41L4A-AS2]]
+
|[[FR0257520]]
−
|FLJ11235
+
|NA
−
|EPB41L4A antisense RNA 2 (head to head)
+
|NA
−
|_
+
|pathogenic process
 +
|prostate cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''ERC2-IT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290104 HSALNT0290104]
−
|[[ERC2-IT1]]
+
|[[NRG1]]
−
|Po42
+
|NA
−
|ERC2 intronic transcript 1
+
|NA
−
|_
+
|pathogenic process
 +
|lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''ERICH1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289689 HSALNT0289689]
−
|[[ERICH1-AS1]]
+
|[[CDKN2B-AS11]]
−
|N/A
+
|NA
−
|ERICH1 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process;developmental process
 +
|stroke
 +
|Cardiovascular Diseases;Nervous System Diseases
 
|-
 
|-
−
|''EWSAT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289690 HSALNT0289690]
−
|[[EWSAT1]]
+
|[[CDKN2B-AS12]]
−
|FLJ33768
+
|NA
−
|Ewing sarcoma associated transcript 1
+
|NA
−
|Ewing sarcoma
+
|pathogenic process
 +
|glioma
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289691 HSALNT0289691]
 +
|[[CDKN2B-AS13]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|plexiform neurofibroma
 +
|Neoplasms;Nervous System Diseases
 
|-
 
|-
−
|''EXOC3-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289697 HSALNT0289697]
−
|[[EXOC3-AS1]]
+
|[[CDKN2B-AS7]]
−
|N/A
+
|NA
−
|EXOC3 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|acute lymphoblastic leukemia
 +
|Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases
 
|-
 
|-
−
|''EXTL3-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289826 HSALNT0289826]
−
|[[EXTL3-AS1]]
+
|[[FADS1]]
−
|N/A
+
|NA
−
|EXTL3 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|lipid metabolism disorder
 +
|Nutritional and Metabolic Diseases
 
|-
 
|-
−
|''F11-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289698 HSALNT0289698]
−
|[[F11-AS1]]
+
|[[CDKN2B-AS8]]
−
|N/A
+
|NA
−
|F11 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|melanoma
 +
|Neoplasms
 
|-
 
|-
−
|''FAM138A''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289696 HSALNT0289696]
−
|[[FAM138A]]
+
|[[CDKN2B-AS6]]
−
|F379
+
|NA
−
|family with sequence similarity 138 member A
+
|NA
−
|_
+
|pathogenic process
 +
|neuroblastoma
 +
|Neoplasms
 
|-
 
|-
−
|''FAM138B''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289699 HSALNT0289699]
−
|[[FAM138B]]
+
|[[CDKN2B-AS9]]
−
|F379
+
|NA
−
|family with sequence similarity 138 member B
+
|NA
−
|_
+
|pathogenic process
 +
|prostate cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''FAM138C''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289688 HSALNT0289688]
−
|[[FAM138C]]
+
|[[CDKN2B-AS10]]
−
|F379
+
|NA
−
|family with sequence similarity 138 member C
+
|NA
−
|_
+
|pathogenic process
 +
|stroke
 +
|Cardiovascular Diseases;Nervous System Diseases
 
|-
 
|-
−
|''FAM138D''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288950 HSALNT0288950]
−
|[[FAM138D]]
+
|[[ENST00000456816]]
−
|F379
+
|NA
−
|family with sequence similarity 138 member D
+
|NA
−
|_
+
|pathogenic process
 +
|clear cell renal cell cancer
 +
|Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 
|-
 
|-
−
|''FAM138E''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290021 HSALNT0290021]
−
|[[FAM138E]]
+
|[[LOC389332]]
−
|F379
+
|NA
−
|family with sequence similarity 138 member E
+
|NA
−
|_
+
|pathogenic process
 +
|clear cell renal cell cancer
 +
|Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 
|-
 
|-
−
|''FAM138F''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290306 HSALNT0290306]
−
|[[FAM138F]]
+
|[[TMEM72]]
−
|F379
+
|NA
−
|family with sequence similarity 138 member F
+
|NA
−
|_
+
|pathogenic process
 +
|clear cell renal cell cancer
 +
|Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 
|-
 
|-
−
|''FAM13A-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289641 HSALNT0289641]
−
|[[FAM13A-AS1]]
+
|[[BC029135]]
−
|NCRNA00039
+
|NA
−
|FAM13A antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|renal clear cell cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''FAM201A''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290374 HSALNT0290374]
−
|[[FAM201A]]
+
|[[X91348]]
−
|N/A
+
|NA
−
|family with sequence similarity 201 member A
+
|NA
−
|_
+
|pathogenic process
 +
|renal clear cell cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''FAM215A''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289694 HSALNT0289694]
−
|[[FAM215A]]
+
|[[CDKN2B-AS4]]
−
|"APR-2, LINC00530"
+
|NA
−
|family with sequence similarity 215 member A (non-protein coding)
+
|NA
−
|_
+
|pathogenic process
 +
|cancer
 +
|Neoplasms
 
|-
 
|-
−
|''FAM222A-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289692 HSALNT0289692]
−
|[[FAM222A-AS1]]
+
|[[CDKN2B-AS2]]
−
|N/A
+
|NA
−
|FAM222A antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|coronary heart disease
 +
|Cardiovascular Diseases
 
|-
 
|-
−
|''FAM226A''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289693 HSALNT0289693]
−
|[[FAM226A]]
+
|[[CDKN2B-AS3]]
−
|MGC34827
+
|NA
−
|family with sequence similarity 226 member A (non-protein coding)
+
|NA
−
|_
+
|pathogenic process
 +
|intracranial aneurysm
 +
|Cardiovascular Diseases;Nervous System Diseases
 
|-
 
|-
−
|''FAM226B''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289695 HSALNT0289695]
−
|[[FAM226B]]
+
|[[CDKN2B-AS5]]
−
|N/A
+
|NA
−
|family with sequence similarity 226 member B (non-protein coding)
+
|NA
−
|_
+
|pathogenic process
 +
|type 2 diabetes
 +
|Nutritional and Metabolic Diseases;Endocrine System Diseases
 
|-
 
|-
−
|''FAM27E3''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290319 HSALNT0290319]
−
|[[FAM27E3]]
+
|[[T-UCRs]]
−
|MGC42630
+
|NA
−
|family with sequence similarity 27 member E3
+
|NA
−
|_
+
|pathogenic process
 +
|neuroblastoma
 +
|Neoplasms
 
|-
 
|-
−
|''FAM41AY1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289530 HSALNT0289530]
−
|[[FAM41AY1]]
+
|[[51A]]
−
|N/A
+
|NA
−
|"family with sequence similarity 41 member A, Y-linked 1"
+
|splicing regulation
−
|_
+
|pathogenic process
 +
|Alzheimer's disease
 +
|Mental Disorders;Nervous System Diseases
 
|-
 
|-
−
|''FAM41C''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290163 HSALNT0290163]
−
|[[FAM41C]]
+
|[[RAB4B-EGLN2]]
−
|N/A
+
|NA
−
|family with sequence similarity 41 member C
+
|NA
−
|_
+
|pathogenic process
 +
|cancer
 +
|Neoplasms
 
|-
 
|-
−
|''FAM66C''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290167 HSALNT0290167]
−
|[[FAM66C]]
+
|[[RERT]]
−
|N/A
+
|NA
−
|family with sequence similarity 66 member C
+
|NA
−
|_
+
|pathogenic process
 +
|hepatocellular cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''FAM74A3''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0265263 HSALNT0265263]
−
|[[FAM74A3]]
+
|[[LINC00237]]
−
|OTTHUMG00000067149
+
|NCRNA00237
−
|family with sequence similarity 74 member A3
+
|NA
−
|_
+
|pathogenic process
 +
|macrocephaly;obesity
 +
|Musculoskeletal Diseases;Pathological Conditions, Signs and Symptoms;Nutritional and Metabolic Diseases;Physiological Phenomena
 
|-
 
|-
−
|''FAM83H-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0267186 HSALNT0267186]
−
|[[FAM83H-AS1]]
+
|[[LINC01370]]
−
|onco-lncRNA-3
+
|HI-LNC25,HILNC25
−
|FAM83H antisense RNA 1 (head to head)
+
|NA
−
|_
+
|pathogenic process
 +
|type 2 diabetes
 +
|Nutritional and Metabolic Diseases;Endocrine System Diseases
 
|-
 
|-
−
|''FAM87A''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289114 HSALNT0289114]
−
|[[FAM87A]]
+
|[[LINC01574]]
−
|N/A
+
|HI-LNC12,TCONS_00009551
−
|family with sequence similarity 87 member A
+
|NA
−
|_
+
|pathogenic process
 +
|type 2 diabetes
 +
|Nutritional and Metabolic Diseases;Endocrine System Diseases
 
|-
 
|-
−
|''FAS-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290159 HSALNT0290159]
−
|[[FAS-AS1]]
+
|[[PTHLH]]
−
|SAF
+
|NA
−
|FAS antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|brachydactyly
 +
|Musculoskeletal Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities
 
|-
 
|-
−
|''FGF10-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0189394 HSALNT0189394]
−
|[[FGF10-AS1]]
+
|[[NONHSAT028496]]
−
|RP11-473L15.2
+
|CISTR-ACT,CISTRACT,re52431
−
|FGF10 antisense RNA 1
+
|transcriptional regulation
−
|_
+
|pathogenic process
 +
|brachydactyly
 +
|Musculoskeletal Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities
 
|-
 
|-
−
|''FLG-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289862 HSALNT0289862]
−
|[[FLG-AS1]]
+
|[[HELLPAR]]
−
|N/A
+
|LINC-HELLP
−
|FLG antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|HELLP syndrome
 +
|Female Urogenital Diseases and Pregnancy Complications
 
|-
 
|-
−
|''FLVCR1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289904 HSALNT0289904]
−
|[[FLVCR1-AS1]]
+
|[[LINC01125]]
−
|LQK1
+
|NA
−
|FLVCR1 antisense RNA 1 (head to head)
+
|NA
−
|_
+
|pathogenic process
 +
|uremia
 +
|Male Urogenital Diseases
 
|-
 
|-
−
|''FMR1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289544 HSALNT0289544]
−
|[[FMR1-AS1]]
+
|[[AC002511.1]]
−
|"ASFMR1, FMR4"
+
|LINC01531
−
|FMR1 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|enterovirus 71 infection
 +
|Virus Diseases
 
|-
 
|-
−
|''FOXC2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289609 HSALNT0289609]
−
|[[FOXC2-AS1]]
+
|[[AP000688.29]]
−
|ODRUL
+
|AP000688.2
−
|FOXC2 antisense RNA 1
+
|NA
−
|osteosarcoma
+
|pathogenic process
 +
|enterovirus 71 infection
 +
|Virus Diseases
 
|-
 
|-
−
|''FOXG1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289832 HSALNT0289832]
−
|[[FOXG1-AS1]]
+
|[[FFAR2]]
−
|FOXG1-AS
+
|NA
−
|FOXG1 antisense RNA 1 (head to head)
+
|NA
−
|autism spectrum disorders
+
|pathogenic process
 +
|enterovirus 71 infection
 +
|Virus Diseases
 
|-
 
|-
−
|''FRGCA''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290222 HSALNT0290222]
−
|[[FRGCA]]
+
|[[RP4-620F22.3]]
−
|LncRNA-AP001631.9
+
|AC099063.2
−
|"FOXM1-regulated, gastric cancer associated"
+
|NA
−
|gastric cancer
+
|pathogenic process
 +
|enterovirus 71 infection
 +
|Virus Diseases
 
|-
 
|-
−
|''GABPB1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290227 HSALNT0290227]
−
|[[GABPB1-AS1]]
+
|[[RP5-843L14.1]]
−
|N/A
+
|LINC01716
−
|GABPB1 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|enterovirus 71 infection
 +
|Virus Diseases
 
|-
 
|-
−
|''GACAT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0287285 HSALNT0287285]
−
|[[ENST00000441383.1]]
+
|[[MAGEA8-AS1]]
−
|"LINC00876, AC096655.1-002"
+
|RP5-869M20.2
−
|gastric cancer associated transcript 1 (non-protein coding)
+
|NA
−
|gastric cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''GACAT2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289019 HSALNT0289019]
−
|[[ENST00000579368.1]]
+
|[[LHX5-AS1]]
−
|HMlincRNA717
+
|locus4010
−
|gastric cancer associated transcript 2 (non-protein coding)
+
|NA
−
|gastric cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''GACAT3''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288902 HSALNT0288902]
−
|[[ENST00000426539.1]]
+
|[[CAPN10-AS1]]
−
|lncRNA-AC130710
+
|CAPN10-DT,locus959
−
|gastric cancer associated transcript 3 (non-protein coding)
+
|NA
−
|gastric cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''GAPLINC''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289404 HSALNT0289404]
−
|[[GAPLINC]]
+
|[[STAM-AS1]]
−
|TCONSN/A00026238
+
|locus3182
−
|"gastric adenocarcinoma associated, positive CD44 regulator, long intergenic non-coding RNA"
+
|NA
−
|gastric cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''GAS1RR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0148276 HSALNT0148276]
−
|[[GAS1RR]]
+
|[[PTENP1-AS]]
−
|LncRNA-Hh
+
|PTENpg1-asRNA
−
|GAS1 adjacent regulatory RNA
+
|transcriptional regulation
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''GAS6-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289562 HSALNT0289562]
−
|[[GAS6-AS1]]
+
|[[AF116616]]
−
|N/A
+
|NA
−
|GAS6 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|osteosarcoma
 +
|Neoplasms
 
|-
 
|-
−
|''GAS8-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289589 HSALNT0289589]
−
|[[GAS8-AS1]]
+
|[[AK094838]]
−
|N/A
+
|NA
−
|GAS8 antisense RNA 1
+
|NA
−
|_
+